Consumer protection and public health often intersect, as seen in disputes over toothpaste efficacy claims. Analyse the regulatory gaps in India's consumer-health interface.

Q. Consumer protection and public health often intersect, as seen in disputes over toothpaste efficacy claims. Analyse the regulatory gaps in India's consumer-health interface. (15 marks, 250-350 words)

A Consumer Council of India survey found 72% of school children with teeth deterioration and 70% with dental caries, while 90% of toothpaste users still reported gum trouble [1] — showing that a commercial product claim is simultaneously a public health outcome. India regulates the two through separate silos, and the seams between them are where consumers lose.

Where the two domains intersect - Product claims as health determinants: non-medicated toothpaste is licensed as a cosmetic under the Drugs and Cosmetics Act, 1940, conforming to BIS standards [2] — yet it is marketed on therapeutic promises (cavity, gum protection). - Preventive health outcomes thus depend on private product efficacy, not only on state delivery.

Gap 1 — Fragmented architecture - CDSCO (safety/composition), CCPA under the Consumer Protection Act, 2019 (misleading ads) [3], and MoHFW's National Oral Health Division (disease burden) [4] operate independently. No single authority validates a health-efficacy claim.

Gap 2 — Post-facto, not pre-market, claim scrutiny - CCPA's Guidelines on Prevention of Misleading Advertisements, 2022 [3] act only after publication; there is no mandatory pre-vetting of clinical evidence behind health claims, leaving advertising self-regulation to fill the void.

Gap 3 — Evidence deficit - India's national oral-health epidemiology rests on surveys conducted over two decades ago [5]. Without current baseline data, neither regulator can test whether products or programmes work.

Gap 4 — Delivery gap widening consumer dependence - The National Oral Health Programme (2014-15) supports 9,587 dental care units but remains partial in coverage [4]; where public preventive care is thin, households substitute advertised products for care.

The toothpaste dispute is therefore not a narrow labelling issue but a symptom of a consumer-health interface without a common evidentiary standard. A statutory health-claims framework — pre-market substantiation shared between CDSCO and CCPA, backed by a refreshed national oral health survey and full NOHP district coverage — would align market conduct with Article 47's mandate to raise public health, making informed choice a genuine consumer right.

(~330 words)

Sources: 1. “72 p.c. of school children have dental diseases” — The Hindu — Consumer Council survey figures on child dental disease and toothpaste users 2. Drugs and Cosmetics Act, 1940 — CDSCO, MoHFW — non-medicated toothpaste regulated as a cosmetic, BIS standards 3. Guidelines on Prevention of Misleading Advertisements and Endorsements, 2022 — PIB, Dept. of Consumer Affairs — CCPA's mandate over misleading advertisements under the Consumer Protection Act, 2019 4. National Oral Health Division — DGHS, MoHFW — NOHP launch year, 9,587 dental care units, partial coverage 5. Oral health concerns in India — National Library of Medicine (citing MoHFW 2002-03 and 2007-08 surveys) — dated national oral-health epidemiological base